Tue, 07 Aug 2018 09:39:08 GMT
Paul Drayson plans raising $78M via new AI drug research firm's IPO
Paul Drayson, Britain's biotech entrepreneur, is eager to attract $78M through a new AI drug research company's initial public offering, planning to list on the London AIM market the following week.